Phathom Pharmaceuticals Doses First Patient in Phase 2 pHalcon-EoE-201 Trial Evaluating VOQUEZNA in Eosinophilic Esophagitis

First patient dosed, with topline results expected in 2027 pHalcon-EoE-201 is the first large, well-controlled clinical trial of an acid secretory tre...

November 05, 2025 | Wednesday | News
INOVIO Completes BLA Submission for INO-3107, a DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously rece...

November 04, 2025 | Tuesday | News
NeuroKaire and Compass Pathways Partner to Advance AI-Driven Insights Into Psychedelic Therapies for Mental Health

Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health ...

November 03, 2025 | Monday | News
Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Breach of Merger Agreement

Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery...

November 03, 2025 | Monday | News
Avantor Launches Integrated Sterile Sampling and PUPSIT Solutions to Streamline Bioprocessing and Enhance Process Control

  Integrated sterile sampling and PUPSIT solutions streamline bioprocessing, enhance flexibility, and reduce risk while accelerating in-process decis...

November 03, 2025 | Monday | News
Cryoport Sets New Industry Benchmark as First Supply Chain Solutions Provider Certified Under ISO 21973

First Global Supply Chain Solutions Company to Achieve ISO 21973 Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards ...

October 31, 2025 | Friday | News
Biocare Medical and Hamamatsu Announce Strategic Collaboration to Advance Innovation in Spatial Biology

Biocare Medical, a global leader in immunohistochemistry instrumentation, antibodies and reagents, and Hamamatsu Corporation, a worldwide innovator in im...

October 31, 2025 | Friday | News
ChemDiv Expands Partnership to Advance Ratutrelvir, a Rationally Designed Ritonavir-Free Mpro Inhibitor for COVID-19

ChemDiv, a global provider of integrated drug discovery solutions,  announced the extension of its Chemistry, Manufacturing and Controls (CMC) servi...

October 31, 2025 | Friday | News
Codexis and Nitto Denko Avecia Partner to Evaluate ECO Synthesis® Platform for Next-Generation Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, In...

October 31, 2025 | Friday | News
Thermo Fisher Scientific to Acquire Clario for $8.9 Billion to Accelerate Digital Transformation of Clinical Research

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margi...

October 30, 2025 | Thursday | News
Vivos Expands Collaboration with Exubrion Therapeutics to Advance Radioisotope Therapies for Companion Animals

Vivos Inc.  announced enhanced cooperation with Exubrion Therapeutics to advance the use of targeted radioactive isotope technology for multiple ind...

October 30, 2025 | Thursday | News
IN8bio Adds The Ohio State University as New Clinical Site for INB-100 Phase 1 Trial

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune dise...

October 30, 2025 | Thursday | News
Syncell Launches Synlight-Pure Kit to Enable 25 nm Precision Subcellular Proteomic Discovery

New Synlight-Pure™ Kit together with Syncell’s Microscoop® Mint platform achieves high-specificity subcellular proteomic discovery with 25 ...

October 30, 2025 | Thursday | News
Zag Bio Launches with $80 Million Financing to Pioneer Thymus-Targeted Therapies for Autoimmune Diseases

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanis...

October 29, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close